M F Kubik1, A W Stephens, D Schneider
1NeXagen, Inc., Boulder, CO 80301.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers identified high-affinity RNA molecules that bind human alpha-thrombin. One RNA (RNA 16.24) inhibits thrombin-driven clot formation, offering potential therapeutic applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: